Back to trial detailsIntake questionnaire
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Non-Small Cell Lung Cancer
Applying to Memorial Sloan Kettering Cancer Center · New York, New York
Answer a few short questions to share with the research team.
0 of 4 answered